Form 4: Tenaya Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Whittemore Tingley, Chief Medical Officer of Tenaya Therapeutics, Inc., reported multiple transactions in common stock on September 10, 2026.
Summary
- Grant/award: acquired 49,000 Common Stock on September 10, 2026; holds 263,073 after (Direct).
- Grant/award: acquired 293,000 Stock Option (Right to buy) on September 10, 2026; holds 293,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Whittemore Tingley — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Grant/award | Common Stock | 49,000 | — | — | 263,073 |
| 2026-09-10 | Grant/award | Stock Option (Right to buy) | 293,000 | — | — | 293,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Grant/award (49,000 shares) |
| 2026-09-10 | Grant/award (293,000 shares) |
Keywords
insider transaction, Form 4, TNYA, Tenaya Therapeutics, Inc., neutral, Whittemore Tingley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.